What is Retatrutide?
Retatrutide is a next-generation triple-receptor agonist that simultaneously targets the GLP-1, GIP, and Glucagon receptors. It represents a significant clinical advance over single or dual-receptor compounds, offering superior metabolic control and body composition outcomes in a convenient pen-format delivery system.
How does it work?
By activating three complementary metabolic receptor pathways at once, Retatrutide delivers a synergistic effect: it reduces appetite, improves insulin sensitivity, increases energy expenditure, and supports fat metabolism simultaneously. The result is a more comprehensive metabolic intervention than any single-target compound can achieve.
Key Benefits
- Advanced body composition and metabolic support
- Appetite regulation without stimulant side effects
- Improved insulin sensitivity and glucose control
- Increased basal metabolic rate
- Convenient, pre-dosed pen format — no reconstitution required
- Available in 6mg and 12mg dose configurations
Who is it for?
Retatrutide is dispensed exclusively to private patients who have undergone a full medical evaluation. It is suitable for adults seeking advanced metabolic optimisation under clinical supervision, particularly those who have not achieved their goals through lifestyle intervention alone.
All protocols are issued following a mandatory medical evaluation. Infinity Lab provides access to premium compounds for private patients under expert guidance. For educational purposes only.
